Drug Trial Radar · NCT02015520
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
Last checked: Nov 20, 2026Latest source record: May 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
143
Actual
Start
Jun 2012
Primary completion
Jun 2013
Study completion Jun 2015
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Dec 19, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to identify an appropriate dose of study medication.
Conditions
- Rheumatoid Arthritis
Interventions
ClazakizumabDrug
Placebo (Matching with Clazakizumab)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Disease Activity Score in 28 Joints - C-reactive Protein (DAS28-CRP) at Week 12Time frame: Baseline and Week 12
Locations
55 sites in 9 countries. Site status is shown where the registry gives one.
Rheumatology Associates Of North Alabama, P.C.
Huntsville, Alabama
Mercy Clinic Hot Springs Communities
Hot Springs, Arkansas
Valerius Med Group & Res Ctr Of Greater Long Beach, Inc.
Long Beach, California
Desert Medical Advances
Palm Desert, California
Sarasota Arthritis Research Center
Sarasota, Florida
Clinical Pharmacology Study Group
Worcester, Massachusetts
St. Paul Rheumatology, P.A.
Eagan, Minnesota
Physician Research Collaboration, Llc
Lincoln, Nebraska
Albuquerque Center For Rheumatology
Albuquerque, New Mexico
Albuquerque Clinical Trials
Albuquerque, New Mexico
Joint And Muscle Medical Care And Research Institute (Jmmcri)
Charlotte, North Carolina
Physicians East, Pa
Greenville, North Carolina
Cincinnati Rheumatic Disease Study Group
Cincinnati, Ohio
Paramount Medical Research & Consulting, Llc
Middleburg Heights, Ohio
Arthritis & Rheumatology Center Of Oklahoma Pllc
Oklahoma City, Oklahoma
Health Research Of Oklahoma
Oklahoma City, Oklahoma
Healthcare Research Consultants
Tulsa, Oklahoma
Low Country Rheumatology
Charleston, South Carolina
Rheumatology Consultants Pllc
Knoxville, Tennessee
Center For Inflammatory Disease
Nashville, Tennessee
Seattle Rheumatology Associates
Seattle, Washington
Local Institution
Buenos Aires, Argentina
Local Institution
Buenos Aires, Argentina
Local Institution
Córdoba, Argentina
Local Institution
San Miguel de Tucumán, Argentina
Local Institution
Quilmes, Buenos Aires, Argentina
Cividino Medicine Professional Corporation
Hamilton, Ontario, Canada
Credit Valley Rheumatology
Mississauga, Ontario, Canada
Dr. Latha Naik Medical Professional Corporation
Saskatoon, Saskatchewan, Canada
Local Institution
Bordeaux, France
Local Institution
Paris, France
Local Institution
Poitiers, France
Local Institution
Budapest, Hungary
Local Institution
Debrecen, Hungary
Local Institution
Veszprém, Hungary
Local Institution
Catanzaro, Italy
Local Institution
Florence, Italy
Local Institution
Naples, Italy
Local Institution
Pisa, Italy
Local Institution
Chiba, Chiba, Japan
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.